thumbnail image

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
    • PanCanSeek
    • LungCanSeek
    • PetCanSeek
    • SeekInEZ
    • SeekInJoy
    • PHLseek
    • EGFRseek
    • OncoGraph
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
      • PanCanSeek
      • LungCanSeek
      • PetCanSeek
      • SeekInEZ
      • SeekInJoy
      • PHLseek
      • EGFRseek
      • OncoGraph
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LeukoPrint
    • PanCanSeek
    • LungCanSeek
    • PetCanSeek
    • SeekInEZ
    • SeekInJoy
    • PHLseek
    • EGFRseek
    • OncoGraph
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LeukoPrint
      • PanCanSeek
      • LungCanSeek
      • PetCanSeek
      • SeekInEZ
      • SeekInJoy
      • PHLseek
      • EGFRseek
      • OncoGraph
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry
  • PetCanSeekTM

    Cancer early detection for dogs

    PetCanSeek™ has been developed as a pan-cancer detection service for canines that takes a panoramic view of blood cell-free cancer signatures of canines by shallow whole genome sequencing (sWGS), equipped with proprietary AI- and big data-driven pet cancer score (PCS) algorithm, to detect the signal of cancer at an early stage.

  • Advantages

    Comprehensive

    Can detect molecular cancer signals in all cancer types in canines.

    Non-invasive

    All the test needs is only 4 mL peripheral blood from one blood draw.

    Multivariate PCS algorithm

    The breakthrough multivariate PCS algorithm accurately targets the early signals of cancer with high sensitivity.

    Panoramic view of cancer genome

    Drawing the panoramic map of cancer genome via WGS to capture more cancer signature fingerprints.

    Detected at earlier cancer stage

    Detecting cancer signals at microscopic molecular level to discover the hidden lesions at early stage.

  • Specifications

    ◉ Indicated subjects: Ideal for routine screening of healthy, asymptomatic dogs; Recommended for all seniors (7+ years) and high-risk breeds from age 4

    ◉ Sample requirements: 4 mL peripheral blood

    ◉ Result readout: pet cancer score (PCS)

    ◉ Turnaround time (TAT): 10 working days

  • How it works

    Section image

    Order

    Consult your doctor to order through a local healthcare partner

    Section image

    Blood draw

    4 mL of peripheral blood is collected and delivered to the central lab

    Section image

    Testing

    Detection is performed using next generation sequencing (NGS) platform

    Section image

    Reporting

    Results are ready within 10 working days after the sample arrives at the central lab

  • Please review the instructions to gain a better understanding of PetCanSeekTM and assess whether it meets your needs.

    Download the Instructions

  • References

    Du H, Liu W, Li Y, et al. Genomic profiling of cell-free DNA from dogs with benign and malignant tumors. BMC Res Notes. 2024;17(1):264. Published 2024 Sep 13. doi:10.1186/s13104-024-06932-3

Navigation

Technology

SeekInCare

SeeInCure

SeekInClarity

OncoSeek

Research

Contact Us

10320 Camino Santa Fe, Suite G

San Diego, CA 92121

United States

info@seekincancer.com

© 2024 SeekIn Inc.

All Rights Reserved.

Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
Learn More